Abdominal Pain in Inflammatory Bowel Disease: An Evidence-Based, Multidisciplinary Review

被引:8
|
作者
Coates, Matthew D. [1 ,2 ]
Clarke, Kofi [1 ]
Williams, Emmanuelle [1 ]
Jeganathan, Nimalan [3 ]
Yadav, Sanjay [4 ]
Giampetro, David [5 ]
Gordin, Vitaly [5 ]
Smith, Sadie [5 ]
Vrana, Kent [2 ]
Bobb, Anne [3 ]
Gazzio, Thu Thi [3 ]
Tressler, Heather [1 ]
Dalessio, Shannon [1 ]
机构
[1] Penn State Coll Med, Div Gastroenterol & Hepatol, Dept Med, Hershey, PA 17033 USA
[2] Penn State Coll Med, Dept Pharmacol, Hershey, PA USA
[3] Penn State Coll Med, Dept Surg, Div Colorectal Surg, Hershey, PA USA
[4] Penn State Coll Med, Dept Psychiat, Hershey, PA USA
[5] Penn State Coll Med, Dept Anaesthesiol & Perioperat Med, Hershey, PA USA
基金
美国国家卫生研究院;
关键词
abdominal pain; inflammatory bowel disease; Crohn's disease; ulcerative colitis; QUALITY-OF-LIFE; COGNITIVE-BEHAVIORAL THERAPY; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; MINDFULNESS-BASED THERAPY; CARE RESOURCE UTILIZATION; CROHNS-DISEASE; ULCERATIVE-COLITIS; TRICYCLIC ANTIDEPRESSANTS; BACTERIAL OVERGROWTH; CARBOHYDRATE-DIET;
D O I
10.1093/crocol/otad055
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Abdominal pain is one of the most common and impactful symptoms associated with inflammatory bowel disease (IBD), including both Crohn's disease and ulcerative colitis. A great deal of research has been undertaken over the past several years to improve our understanding and to optimize management of this issue. Unfortunately, there is still significant confusion about the underlying pathophysiology of abdominal pain in these conditions and the evidence underlying treatment options in this context. There is also a relative paucity of comprehensive reviews on this topic, including those that simultaneously evaluate pharmacological and nonpharmacological therapeutic options. In this review, our multidisciplinary team examines evidence for various currently available medical, surgical, and other analgesic options to manage abdominal pain in IBD.
引用
收藏
页数:18
相关论文
共 50 条
  • [21] Inflammatory bowel diseases and human reproduction:A comprehensive evidence-based review
    Stefano Palomba
    Giuliana Sereni
    Angela Falbo
    Marina Beltrami
    Silvia Lombardini
    Maria Chiara Boni
    Giovanni Fornaciari
    Romano Sassatelli
    Giovanni Battista La Sala
    World Journal of Gastroenterology, 2014, 20 (23) : 7123 - 7136
  • [22] Inflammatory bowel diseases and human reproduction: A comprehensive evidence-based review
    Palomba, Stefano
    Sereni, Giuliana
    Falbo, Angela
    Beltrami, Marina
    Lombardini, Silvia
    Boni, Maria Chiara
    Fornaciari, Giovanni
    Sassatelli, Romano
    La Sala, Giovanni Battista
    WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (23) : 7123 - 7136
  • [23] Psychosocial issues in evidence-based guidelines on inflammatory bowel diseases: A review
    Haeuser, Winfried
    Moser, Gabriele
    Klose, Petra
    Mikocka-Walus, Antonina
    WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (13) : 3663 - 3671
  • [24] Psychosocial issues in evidence-based guidelines on inflammatory bowel diseases: A review
    Winfried Huser
    Gabriele Moser
    Petra Klose
    Antonina Mikocka-Walus
    World Journal of Gastroenterology, 2014, (13) : 3663 - 3671
  • [25] Evidence-based clinical practice guidelines for inflammatory bowel disease 2020
    Hiroshi Nakase
    Motoi Uchino
    Shinichiro Shinzaki
    Minoru Matsuura
    Katsuyoshi Matsuoka
    Taku Kobayashi
    Masayuki Saruta
    Fumihito Hirai
    Keisuke Hata
    Sakiko Hiraoka
    Motohiro Esaki
    Ken Sugimoto
    Toshimitsu Fuji
    Kenji Watanabe
    Shiro Nakamura
    Nagamu Inoue
    Toshiyuki Itoh
    Makoto Naganuma
    Tadakazu Hisamatsu
    Mamoru Watanabe
    Hiroto Miwa
    Nobuyuki Enomoto
    Tooru Shimosegawa
    Kazuhiko Koike
    Journal of Gastroenterology, 2021, 56 : 489 - 526
  • [26] Evidence-Based Approach to the Discontinuation of Immunomodulators or Biologics in Inflammatory Bowel Disease
    Miyatani, Yusuke
    Kobayashi, Taku
    DIGESTION, 2023, 104 (01) : 66 - 73
  • [27] Evidence-based clinical practice guidelines for inflammatory bowel disease 2020
    Nakase, Hiroshi
    Uchino, Motoi
    Shinzaki, Shinichiro
    Matsuura, Minoru
    Matsuoka, Katsuyoshi
    Kobayashi, Taku
    Saruta, Masayuki
    Hirai, Fumihito
    Hata, Keisuke
    Hiraoka, Sakiko
    Esaki, Motohiro
    Sugimoto, Ken
    Fuji, Toshimitsu
    Watanabe, Kenji
    Nakamura, Shiro
    Inoue, Nagamu
    Itoh, Toshiyuki
    Naganuma, Makoto
    Hisamatsu, Tadakazu
    Watanabe, Mamoru
    Miwa, Hiroto
    Enomoto, Nobuyuki
    Shimosegawa, Tooru
    Koike, Kazuhiko
    JOURNAL OF GASTROENTEROLOGY, 2021, 56 (06) : 489 - 526
  • [28] Faecal Calprotectin as an evidence-based medicine biomarker of inflammatory bowel disease
    Caro Miro, M. A.
    Gomez Vera, S.
    Herranz Arriero, L.
    Morales Lomas, J. J.
    CLINICA CHIMICA ACTA, 2019, 493 : S509 - S509
  • [29] Evidence-based consensus on opportunistic infections in inflammatory bowel disease (republication)
    Qian, Jiaming
    INTESTINAL RESEARCH, 2018, 16 (02) : 178 - 193
  • [30] Abdominal Pain in Inflammatory Bowel Disease-Epidemiology, Pathophysiology, and Management: A Narrative Review
    Tan, Wei-wei
    Liu, Zi-xuan
    Liu, Xiao-Yan
    Zhang, Wei-bing
    Zheng, Lie
    Zhang, Ya-Li
    Dai, Yan-Cheng
    PAIN AND THERAPY, 2024, 13 (06) : 1447 - 1469